Sign In

Anna Chen

Vice President at Frazier Healthcare Partners

Anna Chen, Ph.D., is a Vice President at Frazier Healthcare Partners, specifically within the Frazier Life Sciences team, which she joined in 2018. She focuses on private investments and company creation in the life sciences sector. Anna has co-led investments in companies such as Eyconis and Blue Water Bio and serves on their boards. Additionally, she is a board observer for firms like Inipharm, Attovia Therapeutics, Architect Therapeutics, and Diagonal Therapeutics. Her prior contributions include involvement in successful investments like Amunix Pharmaceuticals (acquired by Sanofi) and Lengo Therapeutics (acquired by Blueprint Medicines).12

Before joining Frazier, Anna worked as a management consultant at L.E.K. Consulting, advising biotechnology and pharmaceutical companies on strategic planning and R&D. She also served as an entrepreneurial fellow at Flagship Pioneering and mentored startups through the National Science Foundation Innovation Corps program. Anna holds a Ph.D. in Systems Biology from Harvard University and an A.B. in Biochemical Sciences from Harvard College.1

Highlights

Oct 17 · ois.net
Anna Chen | Ophthalmology Innovation Source
Aug 29 · frazierls.com
Team - Frazier Life Sciences -
Team - Frazier Life Sciences -
Jan 7 · businesswire.com
Frazier Healthcare Partners Announces Multiple Promotions on its ...
Frazier Healthcare Partners Announces Multiple Promotions on its ...

Related Questions

What are some of the notable investments Anna Chen has led at Frazier Healthcare Partners?
How did Anna Chen's background in systems biology influence her career in life sciences?
What companies does Anna Chen currently serve on the boards of?
What was Anna Chen's role at L.E.K. Consulting before joining Frazier Healthcare Partners?
Can you provide more details about the startup incubation projects Anna Chen was involved in?
Anna Chen
Anna Chen, photo 1
Anna Chen, photo 2
Add to my network

Location

Menlo Park, California